Article
Cell & Tissue Engineering
Hao Liu, Tianyue Pan, Yifan Liu, Yuan Fang, Gang Fang, Xiaolang Jiang, Bin Chen, Zheng Wei, Shiyang Gu, Peng Liu, Weiguo Fu, Zhihui Dong
Summary: This study reports the 5-year outcomes of a randomized single-blinded noninferiority trial on peripheral blood mononuclear cells (PBMNCs) and purified CD34(+) cells (PCCs) transplantation for treating angiitis-induced critical limb ischemia (AICLI). The results showed similar efficacy and safety for the two types of autoimplants and a satisfactory cumulative return to work (RTW) rate in AICLI patients who underwent cell transplantation.
STEM CELL RESEARCH & THERAPY
(2022)
Article
Cell & Tissue Engineering
Hao Liu, Yuan Fang, Tianyue Pan, Gang Fang, Yifan Liu, Xiaolang Jiang, Bin Chen, Shiyang Gu, Zheng Wei, Peng Liu, Weiguo Fu, Jue Yang, Zhihui Dong
Summary: This study investigated the recurrence conditions of a relatively large cohort of patients with angiitis-induced critical limb ischemia (AICLI). The results showed that patients with AICLI who underwent cell transplantation had a higher risk of recurrence if multiple limbs were involved and if the period of ischemia relief was longer.
STEM CELLS TRANSLATIONAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Xiaolang Jiang, Hao Liu, Tianyue Pan, Shiyang Gu, Yuan Fang, Zheng Wei, Gang Fang, Bin Chen, Junhao Jiang, Yun Shi, Peng Liu, Weiguo Fu, Zhihui Dong
Summary: The study demonstrated that using peripheral blood mononuclear cells for AICLTI treatment has favorable long-term outcomes, improving patients' quality of life, restoring labor competence, and significantly reducing major amputation rates.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Cell & Tissue Engineering
Hao Liu, Tianyue Pan, Yuan Fang, Gang Fang, Yifan Liu, Xiaolang Jiang, Bin Chen, Zheng Wei, Shiyang Gu, Peng Liu, Weiguo Fu, Zhihui Dong
Summary: For patients with angiitis-induced critical limb ischemia (AICLI), cell transplantation using purified CD34(+) cells (PCCs) and peripheral blood mononuclear cells (PBMNCs) is a promising treatment. This study compared the mid-term safety and efficacy of PCCs vs PBMNCs in treating AICLI, finding no significant difference in amputation-free survival rates between the two groups over a 36-month period. PCCs were more effective in relieving rest pain, while PBMNCs showed earlier improvements in the Rutherford classification, indicating potential options based on patient symptoms.
STEM CELLS TRANSLATIONAL MEDICINE
(2021)
Review
Engineering, Biomedical
Zheng Xing, Chen Zhao, Siwen Wu, Chunchen Zhang, Haifeng Liu, Yubo Fan
Summary: Therapeutic angiogenesis provides a potential solution for critical limb ischemia by manipulating blood vessel growth in vivo without the need for extra pharmaceutics and surgery. With the rise of interdisciplinary research, regenerative medicine strategies offer new possibilities for treating various clinical diseases.
Article
Cell Biology
Yipeng Du, Xiaoting Li, Wenying Yan, Zhaohua Zeng, Dunzheng Han, Hong Ouyang, Xiudi Pan, Bihui Luo, Bohua Zhou, Qiang Fu, Dongfeng Lu, Zheng Huang, Zhiliang Li
Summary: The study utilized mutant MetRS to label proteomes of mesenchymal stem cells and demonstrated efficient incorporation of ANL in protein synthesis in ischemic hind limb. The transplanted MSCs significantly improved blood reperfusion and vessel density while reducing inflammation in hindlimb ischemia model. Proteomic analysis revealed differential protein expression in apoptosis and energy metabolism pathways between ischemic and sham groups.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Medicine, General & Internal
Matilde Zamboni, Massimo Pedriali, Luca Ferretto, Sabrina Scian, Francesca Ghirardini, Riccardo Bozza, Romeo Martini, Sandro Irsara
Summary: The development of chronic vascular wounds is a major issue, especially with the aging population and increasing incidence of underlying diseases. Local injection of peripheral blood mononuclear cells may be a promising cell treatment for wound healing, but more research is needed to establish its clinical efficacy.
Article
Cell & Tissue Engineering
Christy Wing Tung Wong, Apurva Sawhney, Yalan Wu, Yi Wah Mak, Xiao Yu Tian, Hon Fai Chan, Anna Blocki
Summary: This study demonstrated that functional BDACs can be sourced under xeno- and/or serum-free conditions and showed superior therapeutic effects compared to traditional MSCs in a murine model of CLI. The secretome of BDACs contained a larger number of proteins with pro-angiogenic and anti-inflammatory properties, potentially contributing to their enhanced therapeutic potential.
STEM CELL RESEARCH & THERAPY
(2022)
Review
Cell & Tissue Engineering
Laura Lozano Navarro, Xueyi Chen, Lady Tatiana Girata Viviescas, Andrea K. Ardila-Roa, Maria L. Luna-Gonzalez, Claudia L. Sossa, Martha L. Arango-Rodriguez
Summary: Peripheral arterial disease affects hundreds of millions of people worldwide and can lead to limb amputation or death. Revascularization is crucial for preventing amputation, but a significant portion of patients are not suitable for traditional surgical treatment, resulting in higher amputation rates. Mesenchymal stem cells have emerged as a promising cell-based therapy for peripheral arterial disease due to their regenerative properties.
STEM CELL RESEARCH & THERAPY
(2022)
Article
Medicine, General & Internal
Alessia Scatena, Pasquale Petruzzi, Filippo Maioli, Francesca Lucaroni, Cristina Ambrosone, Giorgio Ventoruzzo, Francesco Liistro, Danilo Tacconi, Marianna Di Filippi, Nico Attempati, Leonardo Palombi, Leonardo Ercolini, Leonardo Bolognese
Summary: The study showed that treatment with autologous PBMNC implants in NO-CLI patients with DFUs significantly reduced amputation rate, improved survival, and promoted wound healing. Autologous PBMNC injection may effectively prevent amputations in patients with DFUs.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Medicine, General & Internal
Bobak Moazzami, Zinat Mohammadpour, Zohyra E. Zabala, Ermia Farokhi, Aria Roohi, Elena Dolmatova, Kasra Moazzami
Summary: This study aimed to assess the benefits and harms of local intramuscular transplantation of autologous adult bone marrow mononuclear cells (BMMNCs) as a treatment for critical limb ischaemia (CLI). The results showed that there is currently no clear evidence for the effectiveness of BMMNCs compared to the control group in the treatment of CLI. Larger randomized controlled trials are needed to validate the efficacy of this procedure.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(2022)
Article
Cardiac & Cardiovascular Systems
Waseem Wahood, Sue Duval, Edwin A. Takahashi, Eric A. Secemsky, Sanjay Misra
Summary: This study analyzes the disparities in the treatment of critical limb ischemia (CLI) among different races over a 14-year period. The findings indicate that non-White patients are more likely to receive invasive treatments, including major amputations and revascularization, compared with White patients.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Biochemistry & Molecular Biology
Giulio Rusconi, Giuseppe Cusumano, Luca Mariotta, Reto Canevascini, Mauro Gola, Rosalba Gornati, Gianni Soldati
Summary: Advanced cell therapy medicinal products (ATMP) are a new approach to treating diseases that are not effectively managed with conventional treatments. Good Manufacturing Practices (GMP), the worldwide recognized standard for drug production, also applies to ATMP. This report describes the pre-clinical and GMP upgrade of peripheral blood mononuclear cell (PBMC) preparation, as well as the evaluation of PBMC production in hypoxic conditions. The results suggest that the whole manufacturing process can be performed for clinical application.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Cell & Tissue Engineering
Pegah Nammian, Seyedeh-Leili Asadi-Yousefabad, Sajad Daneshi, Mohammad Hasan Sheikhha, Seyed Mohammad Bagher Tabei, Vahid Razban
Summary: The study compared the effects of allogeneic bone marrow mesenchymal stem cells (BM-MSCs) and adipose tissue mesenchymal stem cells (AT-MSCs) in the treatment of critical limb ischemia (CLI). The results indicated that BM-MSCs had a stronger effect on endothelial cell migration, muscle restructure, functional improvements, and neovascularization in ischemic tissues compared to AT-MSCs. This suggests that BM-MSC transplantation could be a more effective therapy for diseases with insufficient angiogenesis, such as hindlimb ischemia.
STEM CELL RESEARCH & THERAPY
(2021)
Article
Medicine, General & Internal
Nunzio Montelione, Vincenzo Catanese, Teresa Gabellini, Francesco Alberto Codispoti, Antonio Nenna, Francesco Spinelli, Francesco Stilo
Summary: This study reported the early and mid-term outcomes of arterialization of the deep venous system in patients with no-option CLTI. The study used duplex ultrasound and angiographic evaluation to improve limb perfusion. The results showed that this method is feasible and effective in limb salvage.